){kind=logo}
){kind=logo}
Is the European secondaries market living up to the hype?
Secondaries have evolved from something founders did quietly to startup news almost as buzzy as a fundraise. Is the European secondaries market worthy of the excitement it’s getting?
- What factors are driving Europe’s secondaries boom?
- Has the market matured enough to realise the potential of this golden moment?
- Is the hype materialising evenly, or are a handful of trophy names soaking up the liquidity while smaller companies struggle?
- Are we about to see the darker side of the cycle, as companies like Anthropic start clawing back control over secondaries trading?
